| scholarly article | Q13442814 |
| P50 | author | Laurie A Rund | Q57074987 |
| P2093 | author name string | D M Kranz | |
| P D Holler | |||
| B K Cho | |||
| A R Lim | |||
| P2860 | cites work | A functional hot spot for antigen recognition in a superagonist TCR/MHC complex | Q27622127 |
| The crystal structures of K(bm1) and K(bm8) reveal that subtle changes in the peptide environment impact thermostability and alloreactivity | Q27631051 | ||
| Structural basis of 2C TCR allorecognition of H-2Ld peptide complexes | Q27758459 | ||
| The immunological synapse: a molecular machine controlling T cell activation | Q28139151 | ||
| Three-dimensional segregation of supramolecular activation clusters in T cells | Q28282528 | ||
| In vitro evolution of a T cell receptor with high affinity for peptide/MHC. | Q30861962 | ||
| Increased TCR avidity after T cell activation: a mechanism for sensing low-density antigen | Q32138624 | ||
| Expression of membrane interleukin 1 by fibroblasts transfected with murine pro-interleukin 1 alpha cDNA. | Q33636477 | ||
| The law of mass action governs antigen-stimulated cytolytic activity of CD8+ cytotoxic T lymphocytes | Q33637736 | ||
| Deficient cellular immunity--finding and fixing the defects | Q33693913 | ||
| Alphabeta T cell receptor interactions with syngeneic and allogeneic ligands: affinity measurements and crystallization | Q33731073 | ||
| The role of T-cell receptor dimerization in T-cell activation. | Q33774239 | ||
| Differences in antigen recognition and cytolytic activity of CD8(+) and CD8(-) T cells that express the same antigen-specific receptor | Q34099738 | ||
| T cell receptor-MHC interactions up close | Q34132920 | ||
| Kinetic proofreading in T-cell receptor signal transduction | Q34285825 | ||
| High-affinity reactions between antigen-specific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins | Q35918289 | ||
| Kinetics of T-cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness | Q36009049 | ||
| Breaking the affinity ceiling for antibodies and T cell receptors | Q36113815 | ||
| Critical role for CD8 in T cell receptor binding and activation by peptide/major histocompatibility complex multimers | Q36375751 | ||
| Analysis of the expression of peptide-major histocompatibility complexes using high affinity soluble divalent T cell receptors | Q36398857 | ||
| Kinetic discrimination in T-cell activation | Q37715642 | ||
| Killer cell immunoglobulin receptors and T cell receptors bind peptide-major histocompatibility complex class I with distinct thermodynamic and kinetic properties. | Q38320280 | ||
| On the dynamics of TCR:CD3 complex cell surface expression and downmodulation | Q40837872 | ||
| Peptide antagonism and T cell receptor interactions with peptide-MHC complexes | Q40996486 | ||
| T-cell-receptor affinity and thymocyte positive selection | Q41192128 | ||
| Lack of strict correlation of functional sensitization with the apparent affinity of MHC/peptide complexes for the TCR. | Q41325800 | ||
| Serial triggering of many T-cell receptors by a few peptide-MHC complexes | Q41346263 | ||
| Qualitative and quantitative differences in T cell receptor binding of agonist and antagonist ligands. | Q41612272 | ||
| Requirements for peptide-induced T cell receptor downregulation on naive CD8+ T cells | Q42259452 | ||
| Efficient T cell activation requires an optimal dwell-time of interaction between the TCR and the pMHC complex | Q44255903 | ||
| Differential transport requirements of HLA and H-2 class I glycoproteins | Q44765538 | ||
| A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists | Q46121537 | ||
| Ligand recognition by alpha beta T cell receptors | Q46222293 | ||
| Ligand-specific oligomerization of T-cell receptor molecules | Q46536198 | ||
| A kinetic window constricts the T cell receptor repertoire in the thymus. | Q52930208 | ||
| Conversion of a T cell antagonist into an agonist by repairing a defect in the TCR/peptide/MHC interface: implications for TCR signaling. | Q55239901 | ||
| Triggering the TCR Complex Causes the Downregulation of Nonengaged Receptors by a Signal Transduction-Dependent Mechanism | Q56922108 | ||
| Les liaisons dangereuses | Q57275500 | ||
| Derivation of a T cell hybridoma variant deprived of functional T cell receptor α and β chain transcripts reveals a nonfunctional α-mRNA of BW5147 origin | Q57275627 | ||
| Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response | Q71169443 | ||
| Correlation between the number of T cell receptors required for T cell activation and TCR-ligand affinity | Q71434427 | ||
| A residue in the center of peptide QL9 affects binding to both Ld and the T cell receptor | Q71755899 | ||
| Kinetics and affinity of reactions between an antigen-specific T cell receptor and peptide-MHC complexes | Q72628246 | ||
| Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex | Q73168752 | ||
| High- and low-potency ligands with similar affinities for the TCR: the importance of kinetics in TCR signaling | Q77769114 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1043-1052 | |
| P577 | publication date | 2001-10-01 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | CD8(-) T cell transfectants that express a high affinity T cell receptor exhibit enhanced peptide-dependent activation | |
| P478 | volume | 194 |
| Q35008122 | A Detailed Mathematical Model Predicts That Serial Engagement of IgE–FcεRI Complexes Can Enhance Syk Activation in Mast Cells |
| Q52323967 | A humanized TCR retaining authentic specificity and affinity conferred potent anti-tumor cytotoxicity. |
| Q42290491 | A unifying mathematical framework for experimental TCR-pMHC kinetic constants |
| Q38598811 | Alanine Mutagenesis in the Complementarity Determining Region 3 of the MTB and HIV-1 Peptide-Bispecific T Cell Receptor Beta Chain Affects Ligand Recognition. |
| Q35076666 | An evolutionary and structural perspective on T cell antigen receptor function |
| Q45012658 | Antibody specific for the peptide.major histocompatibility complex. Is it T cell receptor-like? |
| Q44555210 | Antigen presentation on MHC molecules as a diversity filter that enhances immune efficacy |
| Q58838678 | Breaking the kinetic window of T-cell activation |
| Q44973640 | CD4 enhances T cell sensitivity to antigen by coordinating Lck accumulation at the immunological synapse |
| Q40196365 | Cellular uptake followed by class I MHC presentation of some exogenous peptides contributes to T cell stimulatory capacity |
| Q37148101 | Cellular-level versus receptor-level response threshold hierarchies in T-cell activation |
| Q38011650 | Challenges in T cell receptor gene therapy. |
| Q33229925 | Class II-restricted T cell receptor engineered in vitro for higher affinity retains peptide specificity and function |
| Q38154887 | Co-Receptor CD8-Mediated Modulation of T-Cell Receptor Functional Sensitivity and Epitope Recognition Degeneracy |
| Q41410840 | Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor |
| Q38880784 | Defining novel parameters for the optimal priming and expansion of minor histocompatibility antigen-specific T cells in culture |
| Q36445933 | Design and characterization of a protein superagonist of IL-15 fused with IL-15Rα and a high-affinity T cell receptor |
| Q27652700 | Different Thermodynamic Binding Mechanisms and Peptide Fine Specificities Associated with a Panel of Structurally Similar High-Affinity T Cell Receptors † ‡ |
| Q51538190 | Directed evolution of human T-cell receptors with picomolar affinities by phage display. |
| Q27652612 | Distinct CDR3 conformations in TCRs determine the level of cross-reactivity for diverse antigens, but not the docking orientation |
| Q34436547 | Diversity-oriented approaches for interrogating T-cell receptor repertoire, ligand recognition, and function |
| Q51594643 | Engineered T-cell receptor tetramers bind MHC-peptide complexes with high affinity. |
| Q33375887 | Engineering higher affinity T cell receptors using a T cell display system |
| Q39826149 | Engineering the binding properties of the T cell receptor:peptide:MHC ternary complex that governs T cell activity |
| Q27642839 | Evidence that structural rearrangements and/or flexibility during TCR binding can contribute to T cell activation |
| Q38066211 | Functional avidity: a measure to predict the efficacy of effector T cells? |
| Q36327157 | Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes |
| Q37027170 | Genetic therapies against HIV. |
| Q33303162 | High-affinity TCRs generated by phage display provide CD4+ T cells with the ability to recognize and kill tumor cell lines. |
| Q43238571 | Human MHC Class I-restricted high avidity CD4+ T cells generated by co-transfer of TCR and CD8 mediate efficient tumor rejection in vivo. |
| Q90928077 | Improving T Cell Receptor On-Target Specificity via Structure-Guided Design |
| Q35738738 | Improving TCR Gene Therapy for Treatment of Haematological Malignancies |
| Q26781296 | Lower Affinity T Cells are Critical Components and Active Participants of the Immune Response |
| Q38093572 | Modulation of tumor immunity by soluble and membrane-bound molecules at the immunological synapse. |
| Q37661366 | Pairing computation with experimentation: a powerful coupling for understanding T cell signalling |
| Q37637869 | Potentiation of T Cell Stimulatory Activity by Chemical Fixation of a Weak Peptide-MHC Complex |
| Q34815668 | Probing T cell membrane organization using dimeric MHC-Ig complexes |
| Q73022474 | Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation |
| Q37042011 | Retrogenic modeling of experimental allergic encephalomyelitis associates T cell frequency but not TCR functional affinity with pathogenicity |
| Q37107843 | Role of T cell receptor affinity in the efficacy and specificity of adoptive T cell therapies |
| Q36713758 | Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functions |
| Q36317151 | Stable, soluble, high-affinity, engineered T cell receptors: novel antibody-like proteins for specific targeting of peptide antigens |
| Q44886665 | Strategic mutations in the class I major histocompatibility complex HLA-A2 independently affect both peptide binding and T cell receptor recognition |
| Q27667507 | Structural Basis of Specificity and Cross-Reactivity in T Cell Receptors Specific for Cytochrome c-I-E |
| Q36234904 | T-cell genetic modification for re-directed tumor recognition. |
| Q37363263 | T-cell receptor binding affinities and kinetics: impact on T-cell activity and specificity |
| Q34718133 | T-cell-receptor gene therapy |
| Q30873107 | TCRs with high affinity for foreign pMHC show self-reactivity |
| Q49834468 | Targeting Intramembrane Protein-Protein Interactions: Novel Therapeutic Strategy of Millions Years Old. |
| Q35826370 | Targeting plasmid-encoded proteins to the antigen presentation pathways |
| Q40653197 | The Paradox of Immune Molecular Recognition of α-Galactosylceramide: Low Affinity, Low Specificity for CD1d, High Affinity for αβ TCRs |
| Q33351190 | The SCHOOL of nature: I. Transmembrane signaling |
| Q42321433 | The Serial Engagement Model 17 Years After: From TCR Triggering to Immunotherapy |
| Q34956078 | The T-cell response in patients with cancer |
| Q45869894 | The cationic region from HIV tat enhances the cell-surface expression of epitope/MHC class I complexes |
| Q50073563 | The half-life of the T-cell receptor/peptide-major histocompatibility complex interaction can modulate T-cell activation in response to bacterial challenge |
| Q38026943 | The molecular determinants of CD8 co-receptor function |
| Q85183501 | The space and time frames of T cell activation at the immunological synapse |
| Q47948894 | Thermodynamic and Kinetic Analysis of a Peptide−Class I MHC Interaction Highlights the Noncovalent Nature and Conformational Dynamics of the Class I Heterotrimer |
| Q35583414 | Thymic expression of a T-cell receptor targeting a tumor-associated antigen coexpressed in the thymus induces T-ALL |
| Q33649735 | Transduction of human T cells with a novel T-cell receptor confers anti-HCV reactivity. |
Search more.